Celularity (CELU) vs Shuttle Pharmaceuticals (SHPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Celularity (CELU) has outperformed Shuttle Pharmaceuticals (SHPH) over the past year, losing 73.5% versus a loss of 78.2%. Shuttle Pharmaceuticals is the larger company by market cap ($16.6 million vs $15.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CELU | SHPH |
|---|---|---|
| Share price | $0.463 | $3.49 |
| Market cap | $15.02M | $16.63M |
| 1-day change | -1.05% | -10.51% |
| YTD return | -58.29% | -80.61% |
| 1-year return | -73.54% | -78.19% |
| 5-year return | -99.31% | — |
| EPS (TTM) | $-1.69 | $-16.87 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $26.55M | — |
| Revenue growth (YoY) | -51.03% | — |
| Net income (latest FY) | $-91.72M | $-11.72M |
| Gross margin | 24.39% | — |
| Operating margin | -230.92% | — |
| Net margin | -345.45% | — |
| 52-week high | $2.55 | $44.40 |
| 52-week low | $0.42 | $2.58 |
| Distance from 52-week high | -81.84% | -92.14% |
| Average volume | 3.95M | 41.80K |
| Shares outstanding | 32.45M | 4.76M |
| Employees | 115 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Celularity
CELU stock →Celularity Inc., a cellular and regenerative medicine company, focuses on addressing aging-related disease using novel therapies. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking.
Health Care · Biotechnology: Pharmaceutical Preparations · 115 employees
About Shuttle Pharmaceuticals
SHPH stock →Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
CELU vs SHPH FAQ
Which is bigger, Celularity or Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals (SHPH) is larger, with a market capitalization of $16.63M compared with $15.02M for Celularity (CELU).
Which stock has performed better over the past year, CELU or SHPH?
CELU returned -73.54% over the past 12 months, compared with -78.19% for SHPH (price return, excluding dividends). Past performance does not predict future results.
Are Celularity and Shuttle Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.